AI Article Synopsis
- Gadolinium-based nanoscale MRI contrast agents are emerging as effective tools for tumor detection in medical imaging due to their ability to enhance the signal from gadolinium ions.
- These agents can deliver a high concentration of gadolinium ions to targeted areas and can be modified to include various functionalities for improved imaging.
- The mini-review discusses recent advancements in these contrast agents and offers insights into future developments in the field.
Article Abstract
Gadolinium-based nanoscale magnetic resonance imaging (MRI) contrast agents (CAs) have gained significant momentum as a promising nanoplatform for detecting tumor tissue in medical diagnosis, due to their favorable capability of enhancing the longitudinal relaxivity (r) of individual gadolinium ions, delivering to the region of interest a large number of gadolinium ions, and incorporating different functionalities. This mini-review highlights the latest developments and applications, and simultaneously gives some perspectives for their future development.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1039/c7tb00382j | DOI Listing |
Publication Analysis
Top Keywords
gadolinium-based nanoscale
8
mri contrast
8
contrast agents
8
gadolinium ions
8
nanoscale mri
4
agents tumor
4
tumor imaging
4
imaging gadolinium-based
4
nanoscale magnetic
4
magnetic resonance
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!